VRTXCIK 875320

VERTEX PHARMACEUTICALS INC / MA

EDGAR filings

Customers

2 active

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Latest period

Dec 31, 2025

10-K filed 2026-02-13

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available). Thin bands are named without a figure. Click a band to open its filing.

Customers 2

Companies VRTX discloses as major customers, as a share of VRTX revenue. 2 active, 0 lapsed.

Company	% of VRTX revenue	Est. revenue	Period	Trend	Status	Source
Accredo Health Group, Inc. Non-SEC Accredo Health Group, Inc.	Named	—	FY 2025-12-31	—	Active	10-K 2026-02-13
Accredo Health Group, Inc. 12 % 11 % 11 % < 10 % < 10 % 10-K filed 2026-02-13 Period FY 2025-01-01 to 2025-12-31, FY 2024-01-01 to 2024-12-31Accession 0000875320-26-000056
MCK Distributor MCKESSON CORP	Named	—	FY 2025-12-31	—	Active	10-K 2026-02-13
McKesson Corporation 22 % 26 % 26 % 19 % 17 % 10-K filed 2026-02-13 Period FY 2025-01-01 to 2025-12-31, FY 2024-01-01 to 2024-12-31Accession 0000875320-26-000056

Alerts are coming

Get an email when VRTX's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.